Omeprazol Genkern (Omeprazole)

Omeprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders:

• Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis.
• Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.
• Helicobacter pylori eradication regimens (as adjunct therapy): enhances eradication rates when combined with antibiotics.
• NSA‑induced gastropathy prophylaxis: reduces risk of ulcer formation in patients requiring chronic NSAID therapy.

• Omeprazole irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By inhibiting this final step of acid production, it markedly lowers gastric acidity, allowing the mucosa to heal and reducing reflux‑related irritation. The inhibition persists until new proton pumps are synthesized, providing prolonged acid suppression after each dose.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually transient and self‑limiting.
• Abdominal pain or dyspepsia: occasional discomfort.
• Nausea or vomiting: mild gastrointestinal upset.
• Flatulence: excess gas production.
• Constipation: infrequent bowel habit changes.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis risk.
• Acute interstitial nephritis: renal inflammation.
• Hypomagnesemia: low serum magnesium with prolonged use.
• Vitamin B12 deficiency: reduced absorption over long‑term therapy.
• Stevens‑Johnson syndrome/toxic epidermal necrolysis: severe skin reactions.
• Fracture risk: possible decrease in bone mineral density with long‑term use.

Omeprazole should be used with consideration of the following precautions:

• Assess renal function: dose adjustment may be needed in severe impairment.
• Review hepatic status: use with caution in moderate to severe liver disease.
• Evaluate for infections: prolonged acid suppression can increase risk of gastrointestinal infections.
• Monitor electrolytes: long‑term therapy may affect magnesium and calcium levels.
• Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment.
• Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Omeprazole may interact with several medicines, altering their effectiveness or safety.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet activity may increase cardiovascular event risk.
• Atazanavir and other protease inhibitors: decreased absorption leading to sub‑therapeutic levels.
• Methotrexate (high dose): increased serum concentrations and toxicity risk.

Moderate Interactions (Monitor Closely)

• Warfarin: potential increase in INR; monitor coagulation parameters.
• Digoxin: possible rise in serum levels; observe for toxicity signs.
• Diazepam: enhanced sedation; adjust dose if needed.
• Iron salts: reduced absorption; separate administration by at least 2 hours.